Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Characterization of human platelet binding of recombinant T cell receptor ligand.
A qualitative exploration of the impact of a 12-week group exercise class for those moderately affected with multiple sclerosis.
Structure and Activity of the Acid Sensing Ion Channels.
Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial.
Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging features.
Tacrolimus potently inhibits human osteoclastogenesis induced by IL-17 from human monocytes alone and suppresses human Th17 differentiation.
The impact of environmental infections (parasites) on MS activity.
MP2RAGE Multiple Sclerosis Magnetic Resonance Imaging at 3 T.
Teva to initiate third Phase III trial of oral laquinimod for the treatment of relapsing remitting multiple sclerosis
Multiple sclerosis treatment: current best practice.
Fulminant Central Nervous System Nocardiosis in a Patient Treated With Alemtuzumab For Relapsing-Remitting Multiple Sclerosis.
Raltegravir (Isentress) pilot study in relapsing multiple sclerosis (INSPIRE)
Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma.
Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis.
Disease-modifying therapies in Chinese children with multiple sclerosis.
Building a better sphingosine kinase-1 inhibitor.
Investigating Axonal Damage in Multiple Sclerosis by Diffusion Tensor Spectroscopy.
Mesenchymal stem cells expressing vasoactive intestinal peptide ameliorate symptoms in a model of chronic multiple sclerosis.
Twin studies and the heritability of MS: a conclusion.
Neuromyelitis optica presenting with relapses under treatment with natalizumab: a case report.
Switching From Natalizumab to Fingolimod in Multiple Sclerosis: A French Prospective Study.
Myelination of the nervous system: mechanisms and functions.
MRI in multiple sclerosis: an intra-individual, randomized and multicentric comparison of gadobutrol with gadoterate meglumine at 3 T.
Assessment of cerebral venous return by a novel plethysmography method.
Isolated trigeminal nerve palsy with motor involvement as a presenting manifestation of multiple sclerosis in an equatorial region - a case report.
Pages
« first
‹ previous
…
119
120
121
122
123
124
125
126
127
…
next ›
last »